Examples of 'adalimumab' in a sentence
Meaning of "adalimumab"
Adalimumab is an adjective used to describe something related to or characteristic of a certain type of medication
Show more definitions
- An immunosuppressive drug (trademark Humira) that is a genetically engineered monoclonal antibody administered by subcutaneous injection to treat the symptoms of various autoimmune diseases (such as rheumatoid arthritis, Crohn's disease, and psoriasis). It acts by binding to and blocking the activity of tumor necrosis factor.
How to use "adalimumab" in a sentence
Basic
Advanced
adalimumab
Administration of adalimumab is not recommended during pregnancy.
It was the second generic biosimilar of adalimumab.
Adalimumab is available in other strengths and presentations.
Various formulations of adalimumab are known in the art.
Adalimumab is only prescribed by specialists in these diseases.
Methods of manufacturing stable aqueous formulations of adalimumab.
Distribution of adalimumab into the milk was not determined.
Infliximab was definitively stopped and adalimumab was introduced.
Adalimumab is immunogenic in mice after a single intravenous dose.
Syringe containing stable aqueous formulations of adalimumab.
Adalimumab concentrations in the synovial fluid from several lP.
No clinical sign was observed that could be attributed to adalimumab.
Adalimumab has not been studied in these patient populations.
Trudexa is a medicine containing the active substance adalimumab.
Mg adalimumab administered every other week c.
See also
Humira is a medicine containing the active substance adalimumab.
Infliximab and adalimumab are currently in advanced clinical trials.
Preclinical data on fertility effects of adalimumab are not available.
Adalimumab is a human monoclonal antibody that binds to TNFa.
This patient was being treated with adalimumab.
Adalimumab had already been approved to treat psoriatic arthritis.
No direct comparison between tofacitinib and adalimumab was held.
Adalimumab binds to a specific protein uc.
It has been used in the evaluation of adalimumab and etanercept.
Adalimumab is administered by subcutaneous injection.
They include infliximab and adalimumab.
Tocilizumab versus adalimumab in monotherapy.
Serious adverse reactions have been reported for adalimumab.
Treated with adalimumab or placebo.
In one embodiment the antibody may be rituximab or adalimumab.
It is not known whether adalimumab passes into breast milk.
In another particular embodiment the biological drug is adalimumab.
Comparisons between guselkumab and adalimumab were not performed.
Adalimumab should only be used during pregnancy if clearly needed.
Most preferably the human antibody is adalimumab or denosumab.
Adalimumab was generally well tolerated.
Serious infections have occurred in people taking adalimumab.
Most patients continued on adalimumab after the infection resolved.
No formal studies have been conducted to evaluate the excretion of adalimumab.
Treatment with adalimumab induced significant inhibition of structural changes on radiographs.
The active substance is adalimumab.
Available data suggest that adalimumab does not worsen or cause strictures.
Humira is a medicine that contains the active substance adalimumab.
Adalimumab has not been studied in patients with hepatic or renal impairment.
The PsAQoL has been used to evaluate infliximab and adalimumab.
Adalimumab was transgenically produced in multiple different goats during natural lactation.
Fyzoclad is a medicine that contains the active substance adalimumab.
Purification of the expressed adalimumab can be performed by any standard method.
This was not the case for infliximab and adalimumab.
Exposure of the animals to adalimumab during the toxicity studies could be demonstrated.
